-
1
-
-
0001402874
-
Mechanism of enzyme inhibition by trypsin inhibitor in human urine
-
Kosuzume H, Ashida Y, Takemura Y: Mechanism of enzyme inhibition by trypsin inhibitor in human urine. J Clin Exp Med 125:187-190, 1983.
-
(1983)
J Clin Exp Med
, vol.125
, pp. 187-190
-
-
Kosuzume, H.1
Ashida, Y.2
Takemura, Y.3
-
2
-
-
0023019880
-
Protective effects of urinastatin on tissue degradation
-
Shibutani Y, Kunihiro Y: Protective effects of urinastatin on tissue degradation. Jpn Pharmacol Ther 14:6057, 1986.
-
(1986)
Jpn Pharmacol Ther
, vol.14
, pp. 6057
-
-
Shibutani, Y.1
Kunihiro, Y.2
-
4
-
-
0024425558
-
Urinastatin (Kunitz-type proteinase inhibitor) reducing cisplatin nephrotoxicity
-
Umeki S, Tsukiyama K, Okimoto N, Soejima R: Urinastatin (Kunitz-type proteinase inhibitor) reducing cisplatin nephrotoxicity. Am J Med Sci 298:221-226, 1989.
-
(1989)
Am J Med Sci
, vol.298
, pp. 221-226
-
-
Umeki, S.1
Tsukiyama, K.2
Okimoto, N.3
Soejima, R.4
-
5
-
-
0028800769
-
Preventive effect of ulinastatin on renal scarring in rat model of pyelonephritis induced by direct or ascending infection with Serratia marcescens or Escherichia coli
-
Matsumoto T, Haraoka M, Mizunoe Y, Takahashi K, Kubo S, Sakumoto M, Tanaka M, Kumazawa J: Preventive effect of ulinastatin on renal scarring in rat model of pyelonephritis induced by direct or ascending infection with Serratia marcescens or Escherichia coli. Nephron 69:65-70, 1995.
-
(1995)
Nephron
, vol.69
, pp. 65-70
-
-
Matsumoto, T.1
Haraoka, M.2
Mizunoe, Y.3
Takahashi, K.4
Kubo, S.5
Sakumoto, M.6
Tanaka, M.7
Kumazawa, J.8
-
6
-
-
0027999439
-
Cytoprotective effects of ulinastatin against hypoxic injury to LLC-PK1 cells
-
Nakahama H, Nakanishi T, Sugita M: Cytoprotective effects of ulinastatin against hypoxic injury to LLC-PK1 cells. Nephron 68:411-412, 1994.
-
(1994)
Nephron
, vol.68
, pp. 411-412
-
-
Nakahama, H.1
Nakanishi, T.2
Sugita, M.3
-
7
-
-
0028069602
-
Effect of metabolic acidosis on tubular proteinase activity
-
Huang S, Teschner M, Schaefer RM, Heidland A: Effect of metabolic acidosis on tubular proteinase activity. Nephron 66:344-347, 1994.
-
(1994)
Nephron
, vol.66
, pp. 344-347
-
-
Huang, S.1
Teschner, M.2
Schaefer, R.M.3
Heidland, A.4
-
8
-
-
0022467249
-
Pharmacological activities of a trypsin inhibitor: Urinastatin (Miracrid)
-
Ohnishi H, Kosuzume H, Nobuhara M: Pharmacological activities of a trypsin inhibitor: urinastatin (Miracrid). Pharmacometrics 31:663-675, 1986.
-
(1986)
Pharmacometrics
, vol.31
, pp. 663-675
-
-
Ohnishi, H.1
Kosuzume, H.2
Nobuhara, M.3
-
9
-
-
0013693765
-
Studies on the metabolic fate of ulinastatin (1): Pharmacokinetics in rats, mice and rabbits following a single intravenous dose
-
in Japanese
-
Ohzawa N, Takahashi Y, Tsuchiya T, Ogihara T, Nakai Y, Kohda K, Tanaka S, Ishiguro J: Studies on the metabolic fate of ulinastatin (1): pharmacokinetics in rats, mice and rabbits following a single intravenous dose. Yakubutu Dohtai 5:739-753, 1990 (in Japanese).
-
(1990)
Yakubutu Dohtai
, vol.5
, pp. 739-753
-
-
Ohzawa, N.1
Takahashi, Y.2
Tsuchiya, T.3
Ogihara, T.4
Nakai, Y.5
Kohda, K.6
Tanaka, S.7
Ishiguro, J.8
|